What sector is XAIR in?

Beyond Air, Inc. Common Stock (XAIR) operates in the Technology sector, specifically in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

What is XAIR's market cap?

Beyond Air, Inc. Common Stock (XAIR) has a market capitalization of $5M.

How can I analyze XAIR stock?

Valhalla provides comprehensive analysis for XAIR including institutional trade flow, dark pool activity, options data, technical indicators, and proprietary scoring. Visit valhalla-labs.io/stocks/XAIR for a full breakdown.

Where can I find institutional trades for XAIR?

Valhalla tracks real-time institutional trade flow for XAIR, including dark pool blocks, lit block trades, and sweep orders. These insights help identify where smart money is positioned.

XAIR

Q: What is XAIR (Beyond Air, Inc. Common Stock)?

Beyond Air, Inc. Common Stock (XAIR) is a technology company in the surgical & medical instruments & apparatus industry. Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It off

Beyond Air, Inc. Common Stock

Technology — SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Valhalla Score 38

$0.52

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Latest News

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026Updated AACR poster data show continued survival follow-up in heavily pre ‑ treated patients following a single intratumoral UNO injection...globenewswire.com — Apr 20, 2026

📊 Key Statistics

Market Cap$5M

P/E Ratio—

EPS (TTM)—

EPS YoY—

Revenue YoY—

Float—

Short Float %—

Inst. Ownership—

Sector RS—

📈 Fundamentals

ROE—

ROIC—

ROA—

Current Ratio—

Debt/Equity—

Gross Margin—

Net Margin—

Dividend Yield—

Next Earnings—

⚡ Options Summary

Call OI—

Put OI—

P/C Ratio (OI)—

Gamma Environment—

Max Pain—

Call Wall—

Put Wall—

🎯 Analyst Estimates

Consensus Target—

High Target—

Low Target—

Analysts—

Upside/Downside—

📋 Quarterly Financials

Period	Revenue	Rev YoY	EPS	EPS YoY	Gross Margin

Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

Type	Strike	Exp	Size	Premium	Time

Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

Type	Price	Size	Value	Venue	Time

Start Free Trial Full insider & congressional trade history

👤 Insider Trades

Name	Type	Shares	Price	Date

Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

Institution	Shares	Value	% of Class